top-cros-in-apac
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

C&R Research: Taking Korea's Pharma Companies International
line

Top 10 CROs in APAC - 2020

line

Owing to the constantly changing pharmaceutical landscape that is increasingly adopting eClinical systems and innovative trial designs, the CRO space is going through a massive transformation. Pharma and biotech organizations are on the lookout for cost-effective and time-efficient drug development services and as a result, there is a high reliance on CROs. Moreover, with APAC providing cheaper but effective alternatives, several pharmaceutical companies are now collaborating with CROs in the region, making it one of the fastest-growing areas across the drug development arena.

The global CRO market is also witnessing an increased adoption of digitization in the form of eClinical tools that use artificial intelligence and machine learning-based platforms, providing CROs an opportunity to stay ahead of their competitors. Top CROs are embracing artificial intelligence-based technologies as an additional value-add component of their research and development services that are offered to pharmaceutical companies.

Many technology-focused CROs are also working toward developing in-house expert teams, which is changing the face of the clinical trial space with the implementation of adaptive, virtual, and remote clinical trials. In order to provide support as an end-to-end solution provider, CROs are leveraging an embedded business model that integrates their services with the collaborating organization’s business strategy.

On the other hand, the growth of biosimilars and biologics markets, the requirement for specialized testing services, and the utilization of advanced technologies in the drug development sector is also spearheading the demand for CROs. By aligning the different technologies with big data, CROs are bringing in innovative offerings that can help organizations make data-driven decisions, elevate the quality of clinical trials, thereby, making their mark on the drug development space. The need for experts in therapeutic areas, regulatory requirements, and pharmacovigilance will steer pharmaceutical and biotech companies to seek specialists in CRO.

Through mergers and acquisitions with data companies, the future of the CRO industry is only going to become stronger. With the drug development facing complexities in the form of rising costs, shorter timelines, and regulatory challenges, CROs will play an important role through their offerings to pharmaceutical companies. To help companies navigate through leading-edge CROs, Pharma Tech Outlook has compiled a list of the “Top 10 CROs in APAC – 2020.” These enterprises are transforming the biotech and pharma industry with their revolutionary technologies and services. This edition also covers insights from industry thought leaders on the latest trends in the APAC region, recent innovations, and their guidance for upcoming leaders in the industry.

We present to you Pharma Tech Outlook’s, “Top 10 CROs in APAC – 2020.”

    Top CROs in APAC

  • C&R Research, established in 1997, is the first full-service CRO in Korea and has grown to become Korea's leading CRO. The company offers full-service coverage, including arranging contracts, drug development consulting, regulatory affairs, medical writing, clinical operation, project management, data management, statistical analysis, CSR writing, medical consulting, quality assurance, publication, education, and training. With a well-established market in Korea, C&R Research's goal is to become a total value chain CRO that provides end-to-end services, including technology investment and incubation, training programs, joint development services, and production distribution

    www.cnrres.com

  • PSI CRO is a leading full-service global Contract Research Organization that brings in an impressive track record of enabling sponsors to complete their studies on time. While the CRO market in the APAC region has been deemed as the fastest growing in the world, PSI CRO enables its clients to take advantage of this rapidly growing clinical trial region and deliver their trials on time and within budget. With more than 2300 staff across more than 50 countries, the global CRO serves biotechnology sponsors in a wide variety of therapeutic areas, such as Gastroenterology, Oncology, Hematology, Infectious Diseases, Multiple Sclerosis, and Rare Diseases. It also meets the need for various aspects in clinical trial conduct, from regulatory, consulting, biostatistics and data management, marketing, to medical writing, monitoring, and more

    www.psi-cro.com

  • ClinActis

    ClinActis

    Established in 2009, ClinActis Pte Ltd is a full service CRO providing clinical trial services to the pharmaceutical, medical device, medical nutrition, and biotech companies in Asia Pacific. ClinActis is committed to implementing international standards in clinical trials. Their ability to deliver high quality results to their clients is based on recruiting and maintaining the best talent within our organization. ClinActis’ senior management is fully accountable for the quality of deliverables to our clients. The company has 27 years experience in Asia Pacific, including Australia/New Zealand, China, Malaysia, Hong Kong, India, Indonesia, the Philippines, Singapore, South Korea, Taiwan, Thailand, Japan, and Vietnam.

  • CMIC, Inc

    CMIC, Inc

    The first company to provide CRO services in Japan, CMIC Group conducts promotion and public relations activities to negotiate with the authorities for the establishment of CROs in Japan. CMIC Group offers extensive services that encompass an entire value-chain of pharmaceutical companies, including manufacturing, sales, and marketing, based on their unique “Pharmaceutical Value Creator” (PVC) business model. The company also offer services to medical device manufacturers, academia, bio-ventures, and medical institutions. Based in Tokyo, they are known to provide prophylaxis and health enhancing services to the public.

  • GreenLight Clinical

    GreenLight Clinical

    Started in 2006, GreenLight Clinical is a global, full-service CRO supporting a range of therapeutic indications. The company aims to simplify processes, build and nurture relationships, lead partnerships via outcomes and drive results. It is established and run by a team of highly-regarded physicians and researchers with a multi-disciplinary skillset, and a proven track record in delivering high-quality research output to our clients. GreenLight Clinical has the beneficial experience of having supported studies in various disease indications throughout Australia, Asia-Pacific, and USA with a strong network of sites and investigators in the field.Started in 2006, GreenLight Clinical is a global, full-service CRO supporting a range of therapeutic indications. The company aims to simplify processes, build and nurture relationships, lead partnerships via outcomes and drive results. It is established and run by a team of highly-regarded physicians and researchers with a multi-disciplinary skillset, and a proven track record in delivering high-quality research output to our clients. GreenLight Clinical has the beneficial experience of having supported studies in various disease indications throughout Australia, Asia-Pacific, and USA with a strong network of sites and investigators in the field.

  • ICON

    ICON

    ICON helps clients accelerate the development of drugs and devices that save lives and improve quality of life. The company offers a full range of consulting, clinical development and commercialisation services from a global network of offices in 40 countries. ICON is a global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organisations. The company focuses its innovation on the factors that are critical to clients, reducing time to market, reducing cost and increasing quality. Also, its global team of experts possesses extensive experience in a broad range of therapeutic areas

  • Novotech

    Novotech

    Internationally recognized as the leading reagional full-service CRO, Novotech is has been instrumental in the success of over a thousand Phase I - IV clinical trials for biotechnology companies. Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. The company obtained the ISO 27001 certification which is the best-known standard in the ISO family providing requirements for an information security management system.

  • PRA Health Sciences

    PRA Health Sciences

    PRA Health Sciences is a global healthcare intelligence partner providing comprehensive clinical development services to the top CROs and best employers worldwide. The company assists in the production of life-saving and life-improving drugs through its robust data management, statistical analysis, clinical trial management, medical writing, and regulatory and drug development consulting. The company drives change by leveraging its robust entrepreneurial mentality, agile infrastructure, data-driven insights, and patient-centric approach to transform clinical research into an accessible, reliable, and convenient care option for patients, caregivers, and their loved ones.

  • Proswell

    Proswell

    Proswell Medical Company is committed to developing a health business by creating an international brand of local CROs and providing a range of quality services for drug R&D evaluation. Proswell places great importance in the design of clinical research programs, proposing evasive plans for the characteristics of experimental drugs, improving research quality, streamlining workflow, and providing high-quality and efficient clinical research services. Proswell has garnered recognition from major pharmaceutical companies, clinical research institutions, and experts for its deep professional background, rigorous work approach and efficient service.

  • Sino Biological

    Sino Biological

    Sino Biological is a global leader in manufacturing affordable, high-quality reagents, including recombinant proteins, antibodies and cDNA clones—all in-house. The company provides an one-stop shop for researchers and pharmaceutical enterprises around the world, helping its customers obtain the best reagents in required amounts to accelerate the pace of discovery and improve human health. Sino Biological is committed to providing high-quality recombinant protein and antibody reagents and to being a one-stop technical services shop. All of its products are independently developed and produced. In addition, it offers pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.